1-8 of 8
Richard L Bennett
Close
Sort by
Journal Articles

NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome

Amin Sobh, Elena Encinas, Alisha M Patel, Greeshma Surapaneni, Emilie Bonilla, Charlotte Leonie Kaestner, Janai Poullard, PA-S, Monica Clerio, Karthik Vasan, Tzipporah Freeman, Dongwen Lv, Daphné Dupéré-Richer, Alberto Riva, Benjamin G Barwick, Daohong Zhou, Lawrence H Boise, Constantine S. Mitsiades, Baek Kim, Richard L Bennett, Navdeep S Chandel, Jonathan D Licht
Journal: Blood
Blood blood.2023022859.
https://doi.org/10.1182/blood.2023022859
Published: 2024
Includes: Supplemental data
Journal Articles

PKR Inhibits Hematopoietic Stem Cell Differentiation

Richard L Bennett, PhD, Michael T. Byrne, DO, Xiaodong Cheng, MD PhD, Mohini Patel, Zeel Patel, Amalin Asous, W. Stratford May, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2443.
https://doi.org/10.1182/blood.V126.23.2443.2443
Published: 2015
Journal Articles

PKR inhibits the DNA damage response, and is associated with poor survival in AML and accelerated leukemia in NHD13 mice

Xiaodong Cheng, Michael Byrne, Kevin D. Brown, Marina Y. Konopleva, Steven M. Kornblau, Richard L. Bennett, W. Stratford May
Journal: Blood
Blood (2015) 126 (13): 1585–1594.
https://doi.org/10.1182/blood-2015-03-635227
Published: 2015
Includes: Supplemental data
Journal Articles

Increased PKR Expression Promotes MDS Evolution to Acute Leukemia in the NHD13 Mouse Model

Michael T. Byrne, DO, Richard L Bennett, PhD, Xiaodong Cheng, MD, PhD, Christopher M Carter, MD, W. Stratford May, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1900.
https://doi.org/10.1182/blood.V124.21.1900.1900
Published: 2014
Journal Articles

PKR Inhibits the DNA Damage Response and Correlates with Poor Clinical Outcomes in AML

Xiaodong Cheng, MD, PhD, Michael T. Byrne, DO, Kevin Brown, PhD, Marina Konopleva, MD PhD, Steven M. Kornblau, MD, Richard L Bennett, PhD, W. Stratford May, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1017.
https://doi.org/10.1182/blood.V124.21.1017.1017
Published: 2014
Journal Articles

PKR regulates proliferation, differentiation, and survival of murine hematopoietic stem/progenitor cells

Xiangfei Liu, Richard L. Bennett, Xiaodong Cheng, Michael Byrne, Mary K. Reinhard, W. Stratford May, Jr
Journal: Blood
Blood (2013) 121 (17): 3364–3374.
https://doi.org/10.1182/blood-2012-09-456400
Published: 2013
Journal Articles

RAX Activates Tumor Suppressor p53.

Yu Pan, PhD, Richard L. Bennett, Ph.D., W. Stratford May, M.D.,Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1449.
https://doi.org/10.1182/blood.V108.11.1449.1449
Published: 2006
Journal Articles

RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection

Richard L. Bennett, William L. Blalock, Dean M. Abtahi, Yu Pan, Sue A. Moyer, W. Stratford May
Journal: Blood
Blood (2006) 108 (3): 821–829.
https://doi.org/10.1182/blood-2005-11-006817
Published: 2006